Page 105 - Demo

No medicament versus calcium hydroxide1036Table 1. continuedNo intracanal medicament (n=385)Calcium hydroxide (n=334)n column % (n) column % (n) p-valueperforation 17 2.3% (9) 2.4% (8)separated instrument 17 1.8% (7) 3.0% (10)Age ≤ 30 159 20.3% (78) 24.3% (81) 0.28231 - 40 158 20.3% (78) 24.0% (80)41 - 50 180 26.0% (100) 24.0% (80)51 - 60 127 20.3% (78) 14,7% (49)61 - 70 75 10.1% (39) 10.8% (36)≥ 70 20 3.1% (12) 2.4% (8)Antibiotics(pre-operative)yes 25 3.9% (15) 3.0% (10) 0.510no 694 96.1% (370) 97.0% (324)* The variables that were not equally distributed over the two cohorts are marked with an asterisk. The subvariables that were not equally distributed over the two cohorts are in italic typeface. P-values ≤ 0.05 were considered signifi cant.† The number of the complications observed in this study were low and they were, therefore, excluded from further analyses.Table 2. The relation between variables and the occurrence of interappointment emergencies.Interappointment emergenciesIncidence Present Absentcolumn % (n) column % (n) p-valueSex male 10.7% 54.5% (42) 54.5% (350) 0.996female 10.7% 45.5% (35) 45.5% (292)Pain (pre-operative) present 12.6% 92.2% (71) 76.9% (494) 0.002 *absent 3.9% 7.8% (6) 23.1% (148)Diagnosis (pre-operative)irreversible pulpitis 9.6% 35.1% (27) 39.7% (255) 0.006 *irreversible pulpitis with apical periodontitis14.3% 20.8% (16) 15.0% (96)symptomatic apical periodontitis14.4% 40.3% (31) 28.7% (184)asymptomatic apical periodontitis2.7% 3.9% (3) 16.7% (107)Abscess (pre-operative)present 43.6% 31.2% (24) 4.8% (31) <0.001 *absent 8.0% 68.8% (53) 95.2% (611)Sinus tract (pre-operative)present 12.7% 11.7% (9) 9.7% (62) 0.572absent 10.5% 88.3% (68) 90.3% (580)Location treated molarupper jaw 10.0% 41.6% (32) 45.0% (289) 0.564lower jaw 11.3% 58.4% (45) 55.0% (353)Annemarie Baaij.indd 103 03-07-2023 09:47